HPV16/18 vaccination to prevent cervical cancer in The Netherlands: Model‐based cost‐effectiveness
Abstract We evaluated the cost‐effectiveness of HPV16/18 vaccination for girls aged 12 years in The Netherlands in addition to cervical cancer screening. For this purpose, we developed a simulation model that describes the relation between each of the high‐risk human papillomavirus (hrHPV) types and cervical disease, allowing the occurrence of multiple type‐specific infections. Model parameters were derived from Dutch cohort studies, including a large population‐based screening trial, and from the national cervical cancer registry. The model satisfactorily reproduced Dutch data on HPV infectio... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2008 |
Reihe/Periodikum: | International Journal of Cancer ; volume 124, issue 4, page 970-978 ; ISSN 0020-7136 1097-0215 |
Verlag/Hrsg.: |
Wiley
|
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-27629223 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://dx.doi.org/10.1002/ijc.24000 |